Ghent University Academic Bibliography

Advanced

Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy

Guido Van Nooten UGent, Frank Caes, Katrien Francois UGent, Yves Van Belleghem UGent, Thierry Bové UGent, GUY VANDENPLAS and Yvo Taeymans (2012) JOURNAL OF HEART VALVE DISEASE. 21(1). p.88-98
abstract
Background and aim of the study: Since January 1990, a variety of mechanical valves (St. Jude Medical, CarboMedics, ATS Medical) have been implanted routinely at the authors' institution. The study aim was to analyze, retrospectively, the 20-year clinical results of those mechanical valves, and to challenge the anticoagulation policy employed over the years. Methods: Between January 1990 and December 2008, a total of 2,108 mechanical valves was inserted into 1,887 consecutive patients (1,346 aortic, 725 mitral, 27 tricuspid, 10 pulmonary). The mean age of the patients was 63 +/- 13.2 years, and the majority (61%) were males. Preoperatively, 71% the patients were in NYHA class >= III (average 3.01). The most frequent comorbidities included: atrial fibrillation (n = 594), coronary disease (n = 567) and diabetes (n = 398). The follow up (99% complete) totaled 13,721 patient-years (pt-yr), and ranged from 12 to 241 months (average 84 months). Results: In-hospital mortality was 5.2% (n = 98, 14 valve-related). Of the 629 late deaths, the majority were cardiac (n = 276). Survival (Kaplan-Meier estimation) was significantly better for aortic valve patients compared to mitral or multiple valve replacement (Mantel-Cox, p <0.0001). The overall linearized incidences (as %/pt-yr) were: valve thrombosis 0.31, thromboembolism 1.08, and bleeding 0.91. However, as repeated events occurred in several patients, the hazard function was not constant. Multivariate analysis (Cox regression model) showed age >70 years (p <0.0001), NYHA class >= III (p <0.0001), non-sinus rhythm (p = 0.001), concomitant coronary artery bypass grafting (p = 0.008) and higher International Normalized Ratio (INR) values (p = 0.013) as significant risk factors for death, with a trend for redo operations (p = 0.052). Multivariate analysis found variable INR, non-sinus rhythm and NYHA class >II as significant risk factors for thromboembolism, while long-acting coumadin and NYHA class >II were significant risk factors for bleeding. Conclusion: This 20-year experience demonstrated excellent clinical outcomes for patients with mechanical prostheses, with no valve structural failure and an acceptable incidence of adverse events. INR values between 2-2.5 for aortic valve patients, and 3-3.5 for mitral valve patients, yielded the fewest major adverse events.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
AORTIC-VALVE, INTENSITY ANTICOAGULATION, FINAL REPORT, REPLACEMENT, PROSTHESES, OUTCOMES, COMPLICATIONS, OCTOGENARIANS, ORAL ANTICOAGULATION, RANDOMIZED-TRIAL
journal title
JOURNAL OF HEART VALVE DISEASE
J. Heart Valve Dis.
volume
21
issue
1
pages
88 - 98
Web of Science type
Article
Web of Science id
000306675300015
JCR category
CARDIAC & CARDIOVASCULAR SYSTEMS
JCR impact factor
1.071 (2012)
JCR rank
96/120 (2012)
JCR quartile
4 (2012)
ISSN
0966-8519
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
3053864
handle
http://hdl.handle.net/1854/LU-3053864
date created
2012-11-16 15:09:44
date last changed
2016-12-19 15:43:35
@article{3053864,
  abstract     = {Background and aim of the study: Since January 1990, a variety of mechanical valves (St. Jude Medical, CarboMedics, ATS Medical) have been implanted routinely at the authors' institution. The study aim was to analyze, retrospectively, the 20-year clinical results of those mechanical valves, and to challenge the anticoagulation policy employed over the years. 
Methods: Between January 1990 and December 2008, a total of 2,108 mechanical valves was inserted into 1,887 consecutive patients (1,346 aortic, 725 mitral, 27 tricuspid, 10 pulmonary). The mean age of the patients was 63 +/- 13.2 years, and the majority (61\%) were males. Preoperatively, 71\% the patients were in NYHA class {\textrangle}= III (average 3.01). The most frequent comorbidities included: atrial fibrillation (n = 594), coronary disease (n = 567) and diabetes (n = 398). The follow up (99\% complete) totaled 13,721 patient-years (pt-yr), and ranged from 12 to 241 months (average 84 months). 
Results: In-hospital mortality was 5.2\% (n = 98, 14 valve-related). Of the 629 late deaths, the majority were cardiac (n = 276). Survival (Kaplan-Meier estimation) was significantly better for aortic valve patients compared to mitral or multiple valve replacement (Mantel-Cox, p {\textlangle}0.0001). The overall linearized incidences (as \%/pt-yr) were: valve thrombosis 0.31, thromboembolism 1.08, and bleeding 0.91. However, as repeated events occurred in several patients, the hazard function was not constant. Multivariate analysis (Cox regression model) showed age {\textrangle}70 years (p {\textlangle}0.0001), NYHA class {\textrangle}= III (p {\textlangle}0.0001), non-sinus rhythm (p = 0.001), concomitant coronary artery bypass grafting (p = 0.008) and higher International Normalized Ratio (INR) values (p = 0.013) as significant risk factors for death, with a trend for redo operations (p = 0.052). Multivariate analysis found variable INR, non-sinus rhythm and NYHA class {\textrangle}II as significant risk factors for thromboembolism, while long-acting coumadin and NYHA class {\textrangle}II were significant risk factors for bleeding. 
Conclusion: This 20-year experience demonstrated excellent clinical outcomes for patients with mechanical prostheses, with no valve structural failure and an acceptable incidence of adverse events. INR values between 2-2.5 for aortic valve patients, and 3-3.5 for mitral valve patients, yielded the fewest major adverse events.},
  author       = {Van Nooten, Guido and Caes, Frank and Francois, Katrien and Van Belleghem, Yves and Bov{\'e}, Thierry and VANDENPLAS, GUY and Taeymans, Yvo},
  issn         = {0966-8519},
  journal      = {JOURNAL OF HEART VALVE DISEASE},
  keyword      = {AORTIC-VALVE,INTENSITY ANTICOAGULATION,FINAL REPORT,REPLACEMENT,PROSTHESES,OUTCOMES,COMPLICATIONS,OCTOGENARIANS,ORAL ANTICOAGULATION,RANDOMIZED-TRIAL},
  language     = {eng},
  number       = {1},
  pages        = {88--98},
  title        = {Twenty years' single-center experience with mechanical heart valves: a critical review of anticoagulation policy},
  volume       = {21},
  year         = {2012},
}

Chicago
Van Nooten, Guido, FRANK CAES, Katrien Francois, Yves Van Belleghem, THIERRY BOVE, GUY VANDENPLAS, and Yvo Taeymans. 2012. “Twenty Years’ Single-center Experience with Mechanical Heart Valves: a Critical Review of Anticoagulation Policy.” Journal of Heart Valve Disease 21 (1): 88–98.
APA
Van Nooten, G., CAES, F., Francois, K., Van Belleghem, Y., BOVE, T., VANDENPLAS, G., & Taeymans, Y. (2012). Twenty years’ single-center experience with mechanical heart valves: a critical review of anticoagulation policy. JOURNAL OF HEART VALVE DISEASE, 21(1), 88–98.
Vancouver
1.
Van Nooten G, CAES F, Francois K, Van Belleghem Y, BOVE T, VANDENPLAS G, et al. Twenty years’ single-center experience with mechanical heart valves: a critical review of anticoagulation policy. JOURNAL OF HEART VALVE DISEASE. 2012;21(1):88–98.
MLA
Van Nooten, Guido, FRANK CAES, Katrien Francois, et al. “Twenty Years’ Single-center Experience with Mechanical Heart Valves: a Critical Review of Anticoagulation Policy.” JOURNAL OF HEART VALVE DISEASE 21.1 (2012): 88–98. Print.